“Reasonable” Limits On Research Fees Needed To Protect Guidelines – Fye
This article was originally published in The Gray Sheet
Executive Summary
Specific caps on corporate compensation for clinical investigators must be established to protect the integrity of ACC/AHA practice guidelines, according to outgoing American College of Cardiology president Bruce Fye, MD, Mayo Clinic
You may also be interested in...
Tunis Presses NIH To Share ICD Study Findings; Dollens Claims Data Irrelevant
CMS will contact the National Heart, Lung & Blood Institute within the next two weeks to try to determine why SCD-HeFT study patients who met the MADIT-II trial criteria were not switched to the active ICD treatment arm
Medical Journals Will Ask Authors To Provide Data On Commercial Interests
A dozen of the most prominent medical journals will now routinely request authors to disclose details of their own role and funders' roles in the study prior to publication, under a revised submission policy.
Kenvue Breaks Ground On New Headquarters, Appoints Chief Corporate Affairs Officer
Firm hosts groundbreaking for 290,000 square-foot global headquarters it’s having built in Summit, NJ, starting with 100,000 square-foot science and innovation and expected to open in 2025. It announced adding Russell Dyer as chief corporate affairs officer starting 13 March.